604 related articles for article (PubMed ID: 25956410)
1. Antifibrinolytic drugs for acute traumatic injury.
Ker K; Roberts I; Shakur H; Coats TJ
Cochrane Database Syst Rev; 2015 May; 2015(5):CD004896. PubMed ID: 25956410
[TBL] [Abstract][Full Text] [Related]
2. Antifibrinolytic drugs for acute traumatic injury.
Roberts I; Shakur H; Ker K; Coats T;
Cochrane Database Syst Rev; 2012; 12():CD004896. PubMed ID: 23418644
[TBL] [Abstract][Full Text] [Related]
3. Antifibrinolytic drugs for acute traumatic injury.
Roberts I; Shakur H; Ker K; Coats T;
Cochrane Database Syst Rev; 2011 Jan; (1):CD004896. PubMed ID: 21249666
[TBL] [Abstract][Full Text] [Related]
4. Antifibrinolytic drugs for treating primary postpartum haemorrhage.
Shakur H; Beaumont D; Pavord S; Gayet-Ageron A; Ker K; Mousa HA
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012964. PubMed ID: 29462500
[TBL] [Abstract][Full Text] [Related]
5. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K
Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD001886. PubMed ID: 21412876
[TBL] [Abstract][Full Text] [Related]
6. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K
Cochrane Database Syst Rev; 2011 Jan; (1):CD001886. PubMed ID: 21249650
[TBL] [Abstract][Full Text] [Related]
7. Antifibrinolytic drugs for acute traumatic injury.
Coats T; Roberts I; Shakur H
Cochrane Database Syst Rev; 2004 Oct; (4):CD004896. PubMed ID: 15495129
[TBL] [Abstract][Full Text] [Related]
8. Topical application of tranexamic acid for the reduction of bleeding.
Ker K; Beecher D; Roberts I
Cochrane Database Syst Rev; 2013 Jul; (7):CD010562. PubMed ID: 23881695
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta-analysis.
Gibbs VN; Champaneria R; Sandercock J; Welton NJ; Geneen LJ; Brunskill SJ; Dorée C; Kimber C; Palmer AJ; Estcourt LJ
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD013295. PubMed ID: 38226724
[TBL] [Abstract][Full Text] [Related]
10. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
Roberts I; Shakur H; Coats T; Hunt B; Balogun E; Barnetson L; Cook L; Kawahara T; Perel P; Prieto-Merino D; Ramos M; Cairns J; Guerriero C
Health Technol Assess; 2013 Mar; 17(10):1-79. PubMed ID: 23477634
[TBL] [Abstract][Full Text] [Related]
11. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; McClelland B; Laupacis A; Fergusson D
Cochrane Database Syst Rev; 2007 Oct; (4):CD001886. PubMed ID: 17943760
[TBL] [Abstract][Full Text] [Related]
12. Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders.
Estcourt LJ; Desborough M; Brunskill SJ; Doree C; Hopewell S; Murphy MF; Stanworth SJ
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009733. PubMed ID: 26978005
[TBL] [Abstract][Full Text] [Related]
13. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
[TBL] [Abstract][Full Text] [Related]
14. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323
[TBL] [Abstract][Full Text] [Related]
15. Tranexamic acid for reducing mortality in emergency and urgent surgery.
Perel P; Ker K; Morales Uribe CH; Roberts I
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD010245. PubMed ID: 23440847
[TBL] [Abstract][Full Text] [Related]
16. Medical interventions for traumatic hyphema.
Gharaibeh A; Savage HI; Scherer RW; Goldberg MF; Lindsley K
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD005431. PubMed ID: 30640411
[TBL] [Abstract][Full Text] [Related]
17. Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions.
Engelen ET; Schutgens RE; Mauser-Bunschoten EP; van Es RJ; van Galen KP
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012293. PubMed ID: 29963686
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a prognostic model to predict death in patients with traumatic bleeding, and evaluation of the effect of tranexamic acid on mortality according to baseline risk: a secondary analysis of a randomised controlled trial.
Perel P; Prieto-Merino D; Shakur H; Roberts I
Health Technol Assess; 2013 Jun; 17(24):1-45, v-vi. PubMed ID: 23782457
[TBL] [Abstract][Full Text] [Related]
19. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
Henry DA; Moxey AJ; Carless PA; O'Connell D; McClelland B; Henderson KM; Sly K; Laupacis A; Fergusson D
Cochrane Database Syst Rev; 2001; (1):CD001886. PubMed ID: 11279735
[TBL] [Abstract][Full Text] [Related]
20. Medical interventions for traumatic hyphema.
Gharaibeh A; Savage HI; Scherer RW; Goldberg MF; Lindsley K
Cochrane Database Syst Rev; 2013 Dec; 12(12):CD005431. PubMed ID: 24302299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
